WILLSEY LANCE

EXEL

WILLSEY LANCE serves as director at Exelixis, Inc. (EXEL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$237.5K

Total Sells

1 trades

$786.0K

Net Position

Net Seller

$548.5K

Companies Traded

FOCL, EXEL

Active Period

May 2022 – Aug 2026

2 total trades

Most Recent

Buy FOCL

Aug 17, 2026 · $237.5K

WILLSEY LANCE's Insider Trading at Exelixis, Inc. (EXEL)

Buys

0 · $0.00

Sells

1 · $786.0K

Total Shares Bought

Total Shares Sold

40,000

EXEL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 13, 2022	Sell	40,000	$19.65	$786.0K	424,415

WILLSEY LANCE's Insider Trading at FOCL (FOCL)

Buys

1 · $237.5K

Sells

0 · $0.00

Total Shares Bought

50,000

Total Shares Sold

FOCL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 17, 2026	Buy	50,000	$4.75	$237.5K	1,291,780

Related Insiders

Ryan Rhodes

director, officer: Chief Executive Officer

FOCLBuy · Aug 17, 2026

Sanket Shah

officer: General Counsel & Corp Sec

FOCLBuy · Aug 17, 2026

Fran Schulz

director

FOCLBuy · Aug 17, 2026

Mary C Beckerle

Director

EXELSell · Aug 12, 2026

Sue Gail Eckhardt

Director

EXELSell · Jun 3, 2026

WYSZOMIERSKI JACK L

Director

EXELSell · Jun 3, 2026

Dana Aftab

officer: EVP, Research and Development

EXELSell · May 28, 2026

Patrick J. Haley

officer: EVP, Commercial

EXELSell · May 22, 2026

Explore More Insider Trading Data

EXEL Insider Trading Activity

View all insider trades at Exelixis, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity